Glucocorticosteroid therapy results in an increase in the number of circulating neutrophils and a decrease in the number of eosinophils. Utilizing the double layer soft agar technique, we examined the effect of physiologic to pharmacologic concentrations of hydrocortisone on the proliferation of human neutrophil progenitors and eosinophil progenitors from peripheral blood and bone marrow. When peripheral blood cultures were studied, eosinophil proliferation was inhibited in a dose-responsive fashion with 10"-40-M hydrocortisone succinate, and comprised 49±4% of the colonies in control cultures and only 4±1% (P < 0.01) at pharmacologic levels of hydrocortisone (10-5 M). The number of neutrophil colonies, on the other hand, increased by 31% when 10-5 M hydrocortisone was added to cultures. In order for corticosteroids to exert this effect, it was necessary to add them within 24 h of the initiation of culture. The effect of hydrocortisone on granulocyte proliferation could not be blocked by progesterone, a structurally analogous steroid. To determine whether hydrocortisone was acting directly on the progenitor cell or via an effector cell, its effect on modulating cell populations and stimulating-factor production was studied. Removal of Erosetting cells and/or adherent cells did not affect the inhibition of eosinophil colony growth or the enhancement of neutrophil colony growth. Furthermore, addition of the potent inhibitor of T cell function, cyclosporin A, failed to affect eosinophil colony frequency, suggesting that inhibition of T cell function was an unlikely explanation for the observed hydrocortisone effect. Leukocyte conditioned media (LCM), derived from peripheral blood mononuclear cells incubated with hydrocortisone, was devoid of both neutrophil and eosinophil colony-stimulating activity, whereas a control LCM stimulated both neutrophil and eosinophil proliferation. The data suggest that the observed hydrocortisone effect on granulocyte colony formation is unlikely to be mediated by an intermediary, and that hydrocortisone acts directly on progenitor cells.
Introduction
Glucocorticosteroid therapy results in changes in the numbers of circulating granulocytes. Characteristically, peripheral blood neutrophilia (1) and eosinopenia are observed (2) . In vitro studies have also demonstrated an effect on granulopoiesis by glucocorticosteroids. Golde reported inhibition of murine in vitro colony-forming cells (CFU-C)' by dexamethasone (3) and Zalman et al. (4) confirmed this finding, demonstrating an 18% decrease in the number of CFU-C when 6 X 1o-8 M dexamethasone was incorporated into the culture. Finally, in a study of the effect of hydrocortisone on human CFU-C, Morra et al. (5) found that 1 mg of hydrocortisone added to in vitro cultures decreased the growth of CFU-C by -24% (5) . Using the Luxol Fast Blue stain, it has been shown that 50% of the circulating CFU-C (6) and 10-40% of the bone marrow CFU-C are eosinophilic, with the remainder being neutrophil/macrophage precursors (7, 8) . To determine whether a differential effect of glucocorticosteroids on eosinophilic and neutrophilic stem cells could be partly responsible for the changes in the levels ofmature neutrophils and eosinophils during glucocorticosteroid therapy, we undertook the present study.
Utilizing the double layer soft agar technique, the effect of physiologic to pharmacologic concentrations of hydrocortisone on the proliferation of human neutrophil progenitors and eosinophil progenitors from peripheral blood and bone marrow was examined. The data show a differential effect on the production of these two types of granulocyte colonies. To define the mechanisms by which hydrocortisone may affect eosinophilic proliferation, additional experiments were performed. The effect of progesterone, a structurally similar steroid which in some systems has been shown to block glucocorticoid binding to receptors (9), was studied. T cells have been shown to produce eosinophilopoietic factors (10) . Thus, to determine whether the steroids act directly on a progenitor cell or indirectly via an effector cell, whole mononuclear cells, monocyte-depleted nonadherent cells, and T-depleted nonadherent cells were cultured with and without hydrocortisone. To further define the role of T cells, cyclosporin A, a potent immunosuppressive agent, which has been shown to inhibit preferentially early T cell activation (I 1), was added to our culture system and the results were compared with those of the hydrocortisone-containing culture. The possibility that hydrocortisone was blocking production of a specific eosinophil colony-stimulating product was examined by preparing leukocyte conditioned media (LCM) from cells cultured with and without hydrocortisone. The data suggest that glucocorticosteroids directly suppress eosinophil colony but not neutrophil colony formation.
Methods
Venous blood or marrow aspirates were collected in preservative-free heparin from healthy volunteers. Whole mononuclear cells (WMNC) (Table I) . Bone marrow, which has a lower proportion of eosinophil colony-forming cells, was similarly inhibited (Table  II) . The frequency of esterase-positive monocyte/macrophage colonies was unaffected by hydrocortisone (3±1 vs. 5±2%). The The effect of hydrocortisone succinate on the total number of colonies (neutrophil, eosinophil, and mixed), and the proportion that were eosinophil. The values were derived from the colonies generated by 5 X i0' peripheral blood NAC and represent the mean of triplicate plates. The percentage of eosinophil colonies was analyzed using one-way analysis of variance followed by Newman-Keuls test. Neut, neutrophil; Eos, eosinophil. growth of peripheral blood neutrophil colonies increased with the addition of hydrocortisone (Fig. 1) . When the effect of the addition of 10-8 M hydrocortisone was compared with control, the total number of colonies decreased by 9.4% and the proportion that were eosinophil colonies decreased by 16.4%. With the addition of 1O0' M hydrocortisone, the total number of colonies decreased by 3.6%, but the proportion that were eosinophilic was 40.2% less than control (P < 0.05). In the presence of pharmacologic concentrations of hydrocortisone (10-6 M), the total number of colonies decreased by 18 .8%, while the decrease in the number of eosinophil colonies was 77.5% (P < 0.01). Finally, at 10-s M, the total number of colonies decreased by 30%, but the number ofeosinophil colonies decreased by 92.2% (P < 0.01). The number ofmixed neutrophil eosinophil colonies observed ranged from 0 to 2% and was not affected by the addition of hydrocortisone. For percentage of eosinophil colonies, the five groups (control, 10-8, 10-7, 10-6, and IO-s M)
were compared using one-way analysis of variance followed by Newman-Keuls test. When hydrocortisone was added to cultures after plating, a progressive loss ofability to decrease eosinophil colony formation was observed over 24 h (Fig. 2) . To determine the reversibility of the hydrocortisone effect, suspensions of peripheral blood NAC were exposed to either IO-' M hydrocortisone or medium alone for 24 h, then the cells were washed three times and plated for colony growth. Hydrocortisone had no significant effect on viable cell yields from control and steroid-treated suspensions. The percentage of trypan blue-excluded cells was 90 and 95% of the starting number, respectively. 24-h exposure to hydrocortisone diminished the frequency of eosinophil colonies in seven of seven experiments (P < 0.009, Wilcoxon Signed Rank test); however, the diminution was less than that observed with continuous hydrocortisone exposure, suggesting partial reversibility (Table III) .
A sample experiment showing the effect of hydrocortisone on eosinophil colony formation by peripheral blood samples depleted of various cell populations is summarized in Table IV. This data is analyzed using a two-way analysis of variance. Results from three separate experiments show that when WMNC were adherent-cell and T-cell depleted, the percentage of eosinophil colonies increased in both control and 10-5 M hydrocortisone-treated cultures. Adherent cell depletion alone was without effect, with an eosinophil colony frequency of49±6%. The same degree of inhibition of eosinophil colony growth was observed in the WMNC, NAC, and T cell-depleted NAC populations cultured with IO-' M hydrocortisone (P < 0.001).
To further examine the possibility that hydrocortisone was specifically suppressing eosinophil CSA production by accessory cell populations, we studied the effect of LCMs prepared with and without hydrocortisone (10-5 M) on peripheral blood mononuclear cell eosinophil colony frequency. Hydrocortisonecontaining LCMs did not stimulate colony formation above the background level of <4 colonies/5 X 1O' cells, whereas the con- Table I . affect the frequency of eosinophil colony formation despite a 95% decrease in colony growth at 10 ,g/ml (Table V) .
Discussion
In vitro (13) and in vivo (14) (8) , and up to 50% ofperipheral blood colonies (6) , selective suppression of eosinophil colonies by corticosteroids could mask an actual increase in neutrophil colonies. Suggestive evidence for this is provided by Joyce and Chervenick (16) , who found enhanced recovery of granulopoiesis when corticosteroids were given to mice treated with cyclophosphamide. Similarly, Niskanen and Squires (9) found enhanced diffusion chamber granulocyte colony formation in mice treated with corticosteroids. We examined the in vitro effect ofglucocorticosteroids on human eosinophil and neutrophil colony formation, and demonstrated that whereas corticosteroids suppress eosinophil colony formation, they actually enhance neutrophil colony formation. When corticosteroids were added to cultures of peripheral blood or marrow, a dose-dependent inhibition ofeosinophil colony formation was observed, with >95% inhibition observed at 10-5 M hydrocortisone. On the other hand, the actual number of neutrophil colonies per I05 cells cultured increased by 31 % when I0-`M hydrocortisone was added to the cultures (P < 0.01). Therefore, although hydrocortisone decreased the total number ofgranulocyte colonies, this decrease was the summation of an increase in neutrophil colony formation and a profound decrease in eosinophil colony growth. The enhancement ofneutrophil colony growth by hydrocortisone was greater in peripheral blood cultures than in marrow cultures. This suggests that the peripheral blood contains a greater number ofless differentiation-restricted (bipotent) granulocyte progenitors, which are capable of being induced to differentiate along either a neutrophil or eosinophil line.
In order for corticosteroids to affect neutrophil and eosinophil proliferation, they had to be added within 24 h of initiation of the cultures (Fig. 2) . If hydrocortisone was added after 24 h, the inhibition of eosinophil colony formation was abrogated. These same experiments demonstrated that hydrocortisone did not exert its effect by lysis of eosinophil colonies, since plates to which hydrocortisone had been added after 24 h contained well-granulated normal appearing eosinophil colonies, in numbers only slightly lower than those in the control cultures. On the other hand, when suspension cultures of peripheral blood NAC were exposed to hydrocortisone for 24 h, only a partial inhibition of subsequent eosinophil colony formation resulted, suggesting there is partial reversibility of the effect. It is also possible that nonaffected cells escaped the drug effect by not entering a proliferative phase, but there is no evidence to support this mechanism.
Niskanen and Squires (9) reported that the stimulatory effect of corticosteroids on granulocyte proliferation in diffusion chambers was blocked by progesterone, and the authors suggested that the mechanism ofthis effect was competition for the steroid receptor. However, since progesterone is capable of inhibiting granulopoiesis in murine systems, the observed blocking effect may have been due to direct inhibition of granulopoiesis as observed by others ( 17). We examined the effect of progesterone when added alone or in combination with hydrocortisone on neutrophil and eosinophil colony formation. Progesterone, in concentrations as'low as 10-8 M, inhibited both eosinophil and neutrophil colony formation by 40%. However, when added in combination with hydrocortisone, it failed to alter the hydrocortisone effect, showing that in this system progesterone does not block the hydrocortisone effect.
We examined whether hydrocortisone suppresses eosinophil colony formation by its effect on potential modulating cell populations. The data suggested that the hydrocortisone effect was not detectably mediated by accessory cell populations, and may have been a direct one on the granulocyte progenitor. Removal of E-rosetting cells and or adherent cells did not affect the inhibition of eosinophil colony growth or the enhancement of neutrophil colony growth by hydrocortisone. When both adherent and E-rosetting cells were removed, hydrocortisone decreased eosinophil growth by 83% and increased neutrophil colony growth by 56%. Furthermore, addition of cyclosporin A, a potent inhibitor of T cell function, failed to affect eosinophil colony frequency when added alone, and when cyclosporin A was added to cultures containing 10-5 M hydrocortisone it failed to alter the previously described response to hydrocortisone. Metcalf ( 18) has reported that when mice are treated with cortisone acetate, the level of measureable colony-stimulating factor in the serum falls sharply. Similarly, Ralph et al. (19) showed that addition of l0-4 M hydrocortisone to macrophage cell lines completely inhibited lipopolysaccharide-induced production ofmyeloid CSA; however, it had no effect on constitutive production of myeloid CSA (19) . To determine whether the inhibition of eosinophil colony formation we observed with hydrocortisone was mediated by a differential suppression of eosinophil CSA by accessory cells, conditioned media was prepared from whole blood mononuclear cells incubated with 10-5 M hydrocortisone and tested for its ability to stimulate eosinophil and neutrophil colony formation by nonadherent blood and marrow mononuclear cells. As previously observed by others (18) , preparations of LCM derived from cells incubated with hydrocortisone were devoid of both neutrophil and eosinophil CSA, whereas control LCMs stimulated 18±4 eosinophil and 20±6 neutrophil colonies per 5 X 101 peripheral blood NAC.
These data indicate that the observed hydrocortisone effect on granulocyte colony formation was unlikely to be mediated by an extracellular humor.
On the basis of cluster transfer experiments (20) , and the partial separability of eosinophil and neutrophil progenitor cells by velocity sedimentation gradients, it has been postulated that eosinophils constitute a separate lineage with their own progenitor cells. Although nothing in the present data contradicts this hypothesis, it does suggest an alternative explanation for the suppression of eosinophil colonies with the simultaneous increase in neutrophils colonies. It is possible that some progenitor cells are bipotent, and can switch from eosinophil to neutrophil commitment by the modulating action of hydrocortisone. However, the nearly complete suppression of eosinophil colony formation and the overall decrease in total granulocyte colony numbers in the presence of hydrocortisone indicates that hydrocortisone inhibits proliferation of those progenitor cells solely committed to eosinophilopoiesis. A possible mechanism for the observed hydrocortisone effect is corticosteroid-induced modulation of cell surface receptors for regulatory molecules. Studies in other systems have shown that glucocorticosteroids are capable ofaltering the number of cell surface receptors for various trophic substances (21) (22) (23) . For example, treatment ofhuman subjects with glucocorticosteroids decreased the number ofadrenergic receptor sites on their mononuclear cells while increasing the number on their neutrophils (23) . Such a differential effect of glucocorticosteroids on eosinophil progenitors vs. neutrophil progenitors may account for the decreased production of eosinophils and increased proliferation of neutrophils.
